How many IPN10200 clinical trials are there?

6 IPN10200 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 5 are actively recruiting participants.

Are IPN10200 clinical trials recruiting in 2026?

Yes — 5 IPN10200 trials are actively recruiting in 2026, with 100 U.S. sites across 26 states. See the recruiting trials and the per-state site list further down this page.

What conditions is IPN10200 being studied for?

IPN10200 is being studied for Moderate to Severe Glabellar Lines, Cervical Dystonia, Chronic Migraine, Episodic Migraine, Moderate to Severe Upper Facial Lines and 1 more. The trials are grouped by indication on this page.

What phase is IPN10200 in?

IPN10200 clinical trials span 2 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors IPN10200 clinical trials?

The lead sponsor across the most IPN10200 trials is Ipsen. Each trial row links to the full study detail page including sponsor information.

IPN10200 Clinical Trials (2026): 6 Studies for Moderate to Severe Glabellar Lines & Cervical Dystonia

Creator: Hipa.ai Research
Published: 2026-05-29T17:34:18.650Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: June 12, 2026.

6 IPN10200 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 5 indications (including Moderate to Severe Glabellar Lines & Cervical Dystonia) and 3,340 total planned enrollment. 2 Phase 3 IPN10200 trials and 2 Phase 2 are listed. 5 IPN10200 clinical trials are actively recruiting at 100 U.S. sites across 26 states. Most recent activity: NCT04752774 (Mar 2029).

Where to Participate: All IPN10200 Trial Sites in the U.S. (100 sites across 26 states)

Every actively recruiting IPN10200trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AL	Skin Wellness Dermatology - Homewood	Birmingham35209	NCT07427797	Map
AL	Rehabilitation & Neurological Services, LLC	Huntsville35801	NCT06625060	Map
AZ	MD First Research - Chandler	Chandler85286	NCT06625060	Map
AZ	MD First Research - Chandler - Neurology	Chandler85224	NCT06625060	Map
AZ	Advanced Research Associates	Glendale85308	NCT07427797	Map
AZ	Investigate MD, LLC	Scottsdale85260	NCT07427797	Map
CA	Profound Research. LLC - NCSC	Carlsbad92011	NCT06625060	Map
CA	Rancho Los Amigos National Rehab	Downey90242	NCT04752774	Map
CA	M3Wake -PRI Encino	Encino91316	NCT06625060	Map
CA	WR-PRI Encino	Encino91316	NCT06625060	Map
CA	Parkinson's & Mvmt Disorders Inst	Fountain Valley92708	NCT06937931	Map
CA	Neuro-Pain Medical Center	Fresno93710	NCT06625060	Map
CA	Fullerton Neurological Center - Neurology	Fullerton92832	NCT06625060	Map
CA	Kaizen Brain Center	La Jolla92037	NCT06625060	Map
CA	Pharmacology Research Institute (PRI)	Los Alamitos90720	NCT06625060	Map
CA	Clinical Testing of Beverly Hills	Los Angeles91436	NCT07435428	Map
CA	Ablon Skin Institute and Research Center	Manhattan Beach90266	NCT07427797	Map
CA	Eye Research Foundation	Newport Beach92663	NCT07435428	Map
CA	Pharmacology Research Institute (PRI) - Los Alamitos/Long Beach	Newport Beach92660	NCT06625060	Map
CA	Steve Yoelin MD Medical Associates Inc	Newport Beach92663	NCT07435428	Map
CA	Profound Research, LLC	Pasadena91105	NCT06625060	Map
CA	Skin and Beauty Center	Pasadena91105	NCT07435428	Map
CA	Keith A. Marcus, MD Inc	Redondo Beach90277	NCT07427797	Map
CA	Ava T. Shamban, M.D., Inc.	Santa Monica90404	NCT07427797	Map
CA	Art of Skin MD	Solana Beach92075	NCT07427797	Map
CA	Clinical Trials Management LLC	Thousand Oaks91360	NCT06625060	Map
CA	Pacific Clinical Innovations Inc.	Vista92083	NCT07427797	Map
CO	Advanced Neuroscience Research Center, LLC	Fort Collins80501	NCT06625060	Map
CO	Advanced Neuroscience Research Center, LLC - Neurology	Fort Collins80524	NCT06625060	Map
CT	DMR Research, PLLC	Westport06880	NCT07435428	Map
FL	Skin and Cancer Associates (SCA) and the Center for Cosmetic Enhancement (CCE) - Aventura	Aventura33180	NCT07435428	Map
FL	Neurology Offices	Boca Raton33432	NCT06625060	Map
FL	Parkinson's Ds & Mvt Disorders Cntr	Boca Raton33486	NCT06937931	Map
FL	Weinkle Dermatology	Bradenton34209	NCT07435428	Map
FL	Skin Research Institute	Coral Gables33146	NCT07427797	Map
FL	M3 Wake Research/MSRA, LLC	Lake City32055	NCT06625060	Map
FL	M3 Wake Research/MSRA,LLC	Lake City32055	NCT06625060	Map
FL	Miami Dermatology & Laser Research	Miami33133	NCT07435428	Map
FL	Renstar Medical Research	Ocala34471	NCT06625060	Map
FL	Emerald Coast Center For Neurological Disorders	Pensacola32502	NCT06625060	Map
GA	Emory Brain Health Center	Atlanta30329	NCT06937931	Map
GA	Kavali Plastic Surgery and Skin Renewal Center	Atlanta30328	NCT07435428	Map
IL	Chicago Cosmetic and Dermatologic Research	Chicago60654-5826	NCT07435428	Map
IL	DeNova Research	Chicago60610	NCT07435428	Map
IN	LASSI - Laser and Skin Surgery Center of Indiana	Indianapolis46260	NCT07435428	Map
KS	Kansas Institute of Research	Overland Park66211	NCT04752774	Map
LA	Crescent City Headache and Neurology Center, LLC	Chalmette70043	NCT06625060	Map
LA	DelRicht Research	New Orleans70112	NCT06625060	Map
LA	DelRicht Research	New Orleans70115	NCT07435428	Map
LA	DelRicht Research at Touro Medical Center	New Orleans70115	NCT06625060	Map
LA	Etre, Cosmetic Dermatology and Laser Center	New Orleans70130	NCT07435428	Map
LA	LSU Healthcare Network Orthopedic & Sports Medicine	New Orleans70115	NCT06625060	Map
MD	MedStar Franklin Square Hospital Center	Baltimore21237	NCT06625060	Map
MD	Medstar Franklin Square Medical Center	Baltimore21237	NCT06625060	Map
MD	MedStar Neurosciences and Rehabilitation Research Network	Baltimore21218	NCT06625060	Map
MD	ICON Dermatology and Aesthetics	Bethesda20852	NCT07427797	Map
MD	Maryland Laser, Skin, & Vein Institute, LLC (MDLSV)	Hunt Valley21030	NCT07435428	Map
MD	Lawrence J. Green, MD. LLC	Rockville20850	NCT07435428	Map
MA	SkinCare Physicians	Chestnut Hill02467	NCT07435428	Map
MA	MedVadis Research	Waltham02451	NCT06625060	Map
MI	Michigan Head Pain & Neurological Institute	Ann Arbor48104	NCT06625060	Map
MI	Michigan Head Pain & Neurological Institute - Neurology/Pain	Ann Arbor48104	NCT06625060	Map
MI	Michigan Center for Research Company	Clarkston48346	NCT07435428	Map
MI	Quest Research Institute	Farmington Hills48334	NCT06937931	Map
MI	Michigan Center of Medical Research	Grand Blanc48439	NCT06625060	Map
MN	Minneapolis Clinic-Neurology	Burnsville55306	NCT06625060	Map
NE	Skin Specialists PC dba Schlessinger MD	Omaha68144	NCT07435428	Map
NH	StracSkin	Portsmouth03801	NCT07435428	Map
NY	Integrative Clinical Trials, LLC	Brooklyn11229	NCT06625060	Map
NY	Rejuva Center at Williams	Latham12110	NCT07435428	Map
NY	The Center for Dermatology, Cosmetic & Laser Surgery	Mount Kisco10549	NCT07435428	Map
NY	Dr. Z. Paul Lorenc MD, Office Of	New York10028	NCT07435428	Map
NY	Ichan Sch of Medicine @ Mt. Sinai	New York10029	NCT06937931	Map
NY	Luxurgery	New York10021	NCT07435428	Map
NY	Skin Search Of Rochester, Inc.	Rochester14623	NCT07435428	Map
NY	Montefiore Medical Center: Headache Center	The Bronx10461	NCT06625060	Map
NY	Upstate Clinical Research Associates	Williamsville14221	NCT06625060	Map
NY	Upstate Clinical Research Associates - Research Center	Williamsville14221	NCT06625060	Map
NC	Aesthetic Solutions P.A.	Chapel Hill27517	NCT07435428	Map
NC	Dermatology, Laser & Vein Specialists of the Carolinas (DLVSC) - Charlotte Office	Charlotte28207	NCT07435428	Map
OH	Neurology Diagnostics, Inc.	Dayton45459	NCT06625060	Map
OH	Nash Research Group, LLC	Powell43065	NCT07435428	Map
OR	Oregon Dermatology and Research Center	Portland97210	NCT07435428	Map
PA	Einstein Physical Medicine and Rehabilitation at Elkins Park	Elkins Park19027	NCT04752774	Map
PA	Paddington Testing Company	Philadelphia19103	NCT07435428	Map
PA	Preferred Primary Care Physicians - Curry Hollow	Pittsburgh15236	NCT06625060	Map
TN	Clinical Neuroscience Solutions, Inc - Memphis	Memphis38119	NCT06625060	Map
TN	Clinical Neuroscience Solutions, Inc.	Memphis38119	NCT06625060	Map
TN	Brian S. Biesman MD, PLLC	Nashville37203	NCT07435428	Map
TN	Tennessee Clinical Research Center	Nashville37215	NCT07435428	Map
TX	Westlake Dermatology & Cosmetic Surgery - Westlake	Austin78746-5059	NCT07427797	Map
TX	The University of Texas Southwestern Medical Center	Dallas75390	NCT04752774	Map
TX	Dermatology and Laser Surgery Center	Houston77004	NCT07427797	Map
TX	Elevate Clinical Research - Houston	Houston77002	NCT06625060	Map
TX	Javara Inc. - Houston, TX	Houston77002	NCT06625060	Map
TX	Javara Inc. - New Caney, TX	New Caney77357	NCT06625060	Map
TX	Pflugerville Dermatology Clinical Research Center, Inc. d/b/a Austin Institute for Clinical Research	Pflugerville78660	NCT07427797	Map
VA	SkinDC	Arlington22209	NCT07427797	Map
WA	Kingfisher Cooperative	Spokane99201	NCT06937931	Map
WA	Puget Sound Neurology - Neurology	Tacoma98409	NCT06625060	Map

IPN10200 clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	Total
P1/P2	1	1	2
P2	2		2
P3	2		2

Recruiting IPN10200 clinical trials (5)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT04752774	LANTIMAA Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.	P1/P2	Spasticity	240	Apr 2021
NCT07435428	LAURITE 2A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows	P3	Moderate to Severe Glabellar Lines	1,300	Feb 2026
NCT06937931	CATALPAA Study of IPN10200 for the Treatment of Cervical Dystonia in Adults	P2	Cervical Dystonia	132	Jun 2025
NCT06625060	MERANTIA Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults	P2	Episodic Migraine	641	Oct 2024
NCT07427797	LAURITE 1A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows	P3	Moderate to Severe Glabellar Lines	300	Feb 2026

IPN10200 clinical trials by indication

Moderate to Severe Glabellar Lines (2)

NCT	Acronym	Phase	Status	Title
NCT07435428	LAURITE 2	P3	recruiting	A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
NCT07427797	LAURITE 1	P3	recruiting	A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

Cervical Dystonia (1)

NCT	Acronym	Phase	Status	Title
NCT06937931	CATALPA	P2	recruiting	A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

Episodic Migraine (1)

NCT	Acronym	Phase	Status	Title
NCT06625060	MERANTI	P2	recruiting	A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Spasticity (1)

NCT	Acronym	Phase	Status	Title
NCT04752774	LANTIMA	P1/P2	recruiting	A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Moderate to Severe Upper Facial Lines (1)

NCT	Acronym	Phase	Status	Title
NCT04821089	LANTIC	P1/P2	active not recruiting	A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

IPN10200 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
LAURITE 2	NCT07435428	P3	recruiting	Moderate to Severe Glabellar Lines	1,300	—
LAURITE 1	NCT07427797	P3	recruiting	Moderate to Severe Glabellar Lines	300	—
CATALPA	NCT06937931	P2	recruiting	Cervical Dystonia	132	—
MERANTI	NCT06625060	P2	recruiting	Episodic Migraine	641	—

All IPN10200 trials (6)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT04752774	LANTIMA	A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.	P1/P2	recruiting	240	Ipsen	Apr 2021
NCT07435428	LAURITE 2	A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows	P3	recruiting	1,300	Ipsen	Feb 2026
NCT06937931	CATALPA	A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults	P2	recruiting	132	Ipsen	Jun 2025
NCT06625060	MERANTI	A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults	P2	recruiting	641	Ipsen	Oct 2024
NCT04821089	LANTIC	A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines	P1/P2	active not recruiting	727	Ipsen	Apr 2021
NCT07427797	LAURITE 1	A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows	P3	recruiting	300	Ipsen	Feb 2026

IPN10200 clinical trials: frequently asked questions

How many IPN10200 clinical trials are there?: 6 IPN10200 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 5 are actively recruiting participants.
Are IPN10200 clinical trials recruiting in 2026?: Yes — 5 IPN10200 trials are actively recruiting in 2026, with 100 U.S. sites across 26 states. See the recruiting trials and the per-state site list further down this page.
What conditions is IPN10200 being studied for?: IPN10200 is being studied for Moderate to Severe Glabellar Lines, Cervical Dystonia, Chronic Migraine, Episodic Migraine, Moderate to Severe Upper Facial Lines and 1 more. The trials are grouped by indication on this page.
What phase is IPN10200 in?: IPN10200 clinical trials span 2 Phase 3, 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors IPN10200 clinical trials?: The lead sponsor across the most IPN10200 trials is Ipsen. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming IPN10200as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.

Related pages on Hipa.ai:

IPN10200 overview